Apellis Pharmaceuticals, a biotech drug company based in Waltham, Mass., recalled more than 61,000 injection needle kits after eight retinal vasculitis cases were reported. The company is pulling 12 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Apellis is exclusively distributing injection kits with ...

(MENAFN- GlobeNewsWire - Nasdaq) U.S. Market on Track to Hit USD 1.02 Billion by 2032, Supported by Hospital Demand, Regulatory Emphasis on Safe Medication Practices, and Growth in Surgical Volumes.

This transformative device advances safety and efficiency in drug preparation, underscoring the startup's journey from solo founder to FDA-cleared innovator. "I am humbly grateful and happy to ...

While nothing is certain yet, Apellis may be homing in on the source of a rare but serious side effect tied to its world-first geographic atrophy drug Syfovre. The safety update comes as the company ...

Credit: Apellis. Syfovre is indicated for the treatment of geographic atrophy secondary to age-related macular degeneration. Apellis announced that as part of its investigation into real-world safety ...

Report Ocean has published a new report on the Filter Needles Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report offers a ...

Report Ocean presents a new report on Filter Needles Market size, share, growth, industry trends, and forecast 2030, covering various industry elements and growth trends helpful for predicting the ...

Support to the market growth comes from shift towards increased safety standards & compliance with more stringent regulatory requirements. Healthcare practitioners are rapidly incorporating filter ...